23andMe cuts 40% of its workforce and discontinues therapeutics division
23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs
Read more at ABC News
-
23andMe to slash 40% of its workforce, end therapeutics program to cut costs
Business - MarketWatch - November 12 -
Genetic testing firm 23andMe cuts 40% of its workforce amid financial struggles
World - The Guardian - November 12 -
23andMe to lay off 40% of its workforce as stock price plummets
Top stories - CBS News - November 12 -
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Business - CNBC - November 12 -
DNA-testing site 23andMe to lay off 40% of its workers
Top stories - BBC News - November 12 -
23andMe Lays Off 40 Percent of its Staff, Ends All Therapy Programs
Business - Inc. - November 12 -
The Associated Press says buyouts and some layoffs are ahead as it seeks to cut its workforce by 8%
Entertainment - ABC News - 2 days ago -
Beyond Inc. to Cut Workforce by About 20%
Business - The Wall Street Journal - October 22
More from ABC News
-
Faulty fentanyl tests spurred NYC’s push to ban mail on Rikers Island
Health - ABC News - 13 hours ago -
Former doctor is sentenced to life in prison after conviction for sexually abusing patients
Health - ABC News - 11 hours ago -
Health advocates in Africa worry Trump will reimpose abortion 'gag rule' governing US aid
Health - ABC News - Yesterday -
What to know about Transgender Day of Remembrance and violence against trans people
Health - ABC News - 2 hours ago -
UN authorizes first mpox vaccine for children in an attempt to control Congo outbreak
Health - ABC News - 22 hours ago